Vanguard Group’s Citius Pharmaceuticals CTXR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $127K | Sell |
80,103
-177,528
| -69% | -$282K | ﹤0.01% | 4126 |
|
|
2025
Q1 | $384K | Hold |
257,631
| – | – | ﹤0.01% | 3938 |
|
|
2024
Q4 | $1.03M | Sell |
257,631
-6,183,197
| -96% | -$24.7M | ﹤0.01% | 3753 |
|
|
2024
Q3 | $3.23M | Buy |
6,440,828
+113,571
| +2% | +$56.9K | ﹤0.01% | 3417 |
|
|
2024
Q2 | $3.69M | Sell |
6,327,257
-677,862
| -10% | -$396K | ﹤0.01% | 3378 |
|
|
2024
Q1 | $6.29M | Buy |
7,005,119
+104,889
| +2% | +$94.1K | ﹤0.01% | 3203 |
|
|
2023
Q4 | $5.22M | Buy |
6,900,230
+72,730
| +1% | +$55K | ﹤0.01% | 3272 |
|
|
2023
Q3 | $4.67M | Buy |
6,827,500
+146,374
| +2% | +$100K | ﹤0.01% | 3281 |
|
|
2023
Q2 | $8.02M | Buy |
6,681,126
+626,798
| +10% | +$752K | ﹤0.01% | 3071 |
|
|
2023
Q1 | $7.08M | Buy |
6,054,328
+40,301
| +0.7% | +$47.2K | ﹤0.01% | 3141 |
|
|
2022
Q4 | $4.75M | Buy |
6,014,027
+199,066
| +3% | +$157K | ﹤0.01% | 3334 |
|
|
2022
Q3 | $7.04M | Buy |
5,814,961
+79,600
| +1% | +$96.3K | ﹤0.01% | 3127 |
|
|
2022
Q2 | $5.28M | Sell |
5,735,361
-481,277
| -8% | -$443K | ﹤0.01% | 3356 |
|
|
2022
Q1 | $11.1M | Buy |
6,216,638
+40,028
| +0.6% | +$71.7K | ﹤0.01% | 3090 |
|
|
2021
Q4 | $9.51M | Buy |
6,176,610
+398,324
| +7% | +$613K | ﹤0.01% | 3235 |
|
|
2021
Q3 | $11.7M | Buy |
5,778,286
+125,473
| +2% | +$255K | ﹤0.01% | 3148 |
|
|
2021
Q2 | $19.7M | Buy |
5,652,813
+586,578
| +12% | +$2.04M | ﹤0.01% | 2855 |
|
|
2021
Q1 | $9.02M | Buy |
5,066,235
+4,311,116
| +571% | +$7.67M | ﹤0.01% | 3206 |
|
|
2020
Q4 | $770K | Buy |
755,119
+182,181
| +32% | +$186K | ﹤0.01% | 3890 |
|
|
2020
Q3 | $596K | Buy |
572,938
+33,589
| +6% | +$34.9K | ﹤0.01% | 3780 |
|
|
2020
Q2 | $609K | Buy |
539,349
+74,943
| +16% | +$84.6K | ﹤0.01% | 3725 |
|
|
2020
Q1 | $279K | Sell |
464,406
-2,822
| -0.6% | -$1.7K | ﹤0.01% | 3803 |
|
|
2019
Q4 | $477K | Hold |
467,228
| – | – | ﹤0.01% | 3808 |
|
|
2019
Q3 | $360K | Buy |
467,228
+14,072
| +3% | +$10.8K | ﹤0.01% | 3872 |
|
|
2019
Q2 | $444K | Buy |
453,156
+342,180
| +308% | +$335K | ﹤0.01% | 3846 |
|
|
2019
Q1 | $158K | Buy |
110,976
+57,011
| +106% | +$81.2K | ﹤0.01% | 3957 |
|
|
2018
Q4 | $56K | Buy |
53,965
+1,350
| +3% | +$1.4K | ﹤0.01% | 4062 |
|
|
2018
Q3 | $90K | Buy |
52,615
+3,500
| +7% | +$5.99K | ﹤0.01% | 4088 |
|
|
2018
Q2 | $113K | Buy |
49,115
+23,063
| +89% | +$53.1K | ﹤0.01% | 4040 |
|
|
2018
Q1 | $81K | Buy |
26,052
+15,002
| +136% | +$46.6K | ﹤0.01% | 4047 |
|
|
2017
Q4 | $43K | Buy |
+11,050
| New | +$43K | ﹤0.01% | 4035 |
|